The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $54.31

Today's change-0.85 -1.54%
Updated September 4 4:02 PM EDT. Delayed by at least 15 minutes.
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $54.31

Today's change-0.85 -1.54%
Updated September 4 4:02 PM EDT. Delayed by at least 15 minutes.

Novo Nordisk A/S down (U.S.)$0.85

Novo Nordisk A/S closed sharply lower Friday, dropping (U.S.)$0.85 or 1.54% to (U.S.)$54.31. Shares have lost 2.55% over the last five days, but have gained 28.33% over the last year to date. This security has outperformed the S&P 500 by 25.62% during the last year.

Key company metrics

  • Open(U.S.) $54.49
  • Previous close(U.S.) $55.16
  • High(U.S.) $54.55
  • Low(U.S.) $53.90
  • Bid / Ask-- / --
  • YTD % change+28.33%
  • Volume667,145
  • Average volume (10-day)1,508,508
  • Average volume (1-month)1,480,821
  • Average volume (3-month)1,343,807
  • 52-week range(U.S.) $41.72 to (U.S.) $60.34
  • Beta1.01
  • Trailing P/E30.40×
  • P/E 1 year forward26.89×
  • Forward PEG1.63×
  • Indicated annual dividend(U.S.) $0.76
  • Dividend yield1.40%
  • Trailing EPS(U.S.) $1.79
Updated September 4 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+31.53%

Based on its net profit margin of 31.53%, Novo Nordisk A/S is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.87%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue27,05925,20024,58522,249
Total other revenue--------
Total revenue27,05925,20024,58522,249
Gross profit23,20021,32620,58618,823
Total cost of revenue3,8593,8743,9993,426
Total operating expense14,57711,34315,42813,680
Selling / general / administrative8,0627,0017,7466,769
Research & development3,0353,2503,8653,654
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0-2,376----
Other operating expenses, total-379-406-182-169
Operating income12,48213,8579,1578,569
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax10,54812,4858,3528,454
Income after tax8,3439,8766,5296,500
Income tax, total2,2052,6091,8231,954
Net income8,3439,8766,5296,500
Total adjustments to net income--------
Net income before extra. items8,3439,8766,5296,500
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8,3439,8766,5296,500
Inc. avail. to common incl. extra. items8,3439,8766,5296,500
Diluted net income8,3439,8766,5296,500
Dilution adjustment----0--
Diluted weighted average shares2,5842,6042,6302,622
Diluted EPS excluding extraordinary itemsvalue per share3.233.792.482.48
Dividends per sharevalue per share0.000.005.110.00
Diluted normalized EPSvalue per share3.233.072.482.48